Gritstone Bio: Funding, Investors & Team (Sep 2026)
Gritstone Oncology is a clinical-stage biotech organization creating growth explicit disease immunotherapies to battle various disease types. Its methodology looks to create a helpful invulnerable reaction by utilizing bits of knowledge into the insusceptible framework's capacity to perceive and obliterate cancer cells by focusing on growth explicit neoantigens. Gritstone Oncology is settled in Emeryville, California, with key capabilities situated in Cambridge, Massachusetts, and Pleasanton, California. It was established in August 2015 and is recorded on the Nasdaq Global Select Market under the ticker image GRTS.
Gritstone Bio has raised $168M across 3 funding rounds on record, the most recent an undisclosed round of $32.5M announced in Apr 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gritstone Bio Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Gritstone Bio Funding Rounds
Gritstone Bio raised $55.0M in a Post-IPO Equity announced in Sep 2021.
10 months later, a Post-IPO Debt of $80.0M was announced in Jul 2022.
1.8 years later, an undisclosed round of $32.5M was announced in Apr 2024.
Gritstone Bio Founders and Leadership Team
No contact details are on record for this team yet.
Gritstone Bio Funding Compared to Other Biotechnology Startups
Gritstone Bio's latest round of $32.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gritstone Bio in Biotechnology and Emeryville
Companies Similar to Gritstone Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Gritstone Bio Funding FAQs
What does Gritstone Bio do?
Gritstone Oncology is a clinical-stage biotech organization creating growth explicit disease immunotherapies to battle various disease types. Its methodology looks to create a helpful invulnerable reaction by utilizing bits of knowledge into the insusceptible framework's capacity to perceive and obliterate cancer cells by focusing on growth explicit neoantigens. Gritstone Oncology is settled in Emeryville, California, with key capabilities situated in Cambridge, Massachusetts, and Pleasanton, California. It was established in August 2015 and is recorded on the Nasdaq Global Select Market under the ticker image GRTS.
How much funding has Gritstone Bio raised?
Gritstone Bio has raised $168M across 3 rounds on record. The most recent is an undisclosed round of $32.5M announced in Apr 2024.
When did Gritstone Bio last raise funding?
Gritstone Bio's most recent funding round on record is an undisclosed round of $32.5M, announced in Apr 2024.
Who is the CEO of Gritstone Bio?
Andrew Allen is listed as CEO at Gritstone Bio.
Where is Gritstone Bio headquartered?
Gritstone Bio is based in Emeryville, California, United States.
How many employees does Gritstone Bio have?
Gritstone Bio is in the 101-250 employee band.
How does Gritstone Bio's funding compare to other Biotechnology startups?
Gritstone Bio's latest round of $32.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Gritstone Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gritstone Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.